510(k) Report

510(k) · Cleared

Recalled · Class II · 2020

Neuroreader Medical Image Processing Software

K140828510(k) TraditionalCleared Feb 4, 2015309-day reviewClass II21 CFR 892.2050Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Brainreader Aps · LLZ System, Image Processing, Radiological

Cleared on Feb 4, 2015 as substantially equivalent to K061855 (Cortechs Labs, Inc., 2006) after a 309-day review. Its family tree reaches back 1 generation to 2006. 1 later device descends from it. It has been recalled once.

Decided
Feb 4, 2015
Review
309 days
Class
Class II
Product code
LLZ
Recalls
1
Predicates
1

Its longest line of descent runs back 1 generation to K061855 (2006). 1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2021: 1 descendant clearedK061855 · Neuroquant · Cortechs Labs, Inc. · 200620052010201520202025
Descendants, by generation 1 generation forward: 1 descendant K061855 · Neuroquant · Cortechs Labs, Inc. · 20060
  1. Root · 1 generation backK061855 NeuroquantCortechs Labs, Inc. · 2006
  2. This deviceK140828 Neuroreader Medical Image Processing SoftwareBrainreader Aps · 2015
  3. Descendant · cites it directly · 0 of its ownK202847 AccuBrainBrainnow Medical Technology Limited · 2021

Most influential descendants

Showing 1 of 1 · See all
  • K202847AccuBrainBrainnow Medical Technology Limited · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K061855NeuroquantCortechs Labs, Inc.2006—
0 (this device)K140828Neuroreader Medical Image Processing SoftwareBrainreader Aps2015—
+1K202847AccuBrainBrainnow Medical Technology Limited2021—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
FIG. 1 — Lineage of K140828, 2006–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K061855Neuroquant
Summary page 5
…ation name: Picture archiving and communication system (LLZ) Predicate device: 510(k) reg. no Manufacturer Device Product code K061855 CorTechs Labs, Inc. NeuroQuantTM LLZ Medica…
Cortechs Labs, Inc.2006—

Also cleared against K061855: 5 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K202847AccuBrainBrainnow Medical Technology Limited20210

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 14, 2020Class IIZ-0934-2021Under Investigation by firmThe Neuroreader has been distributed with a reference normative database that is different from the version reviewed and cleared by FDA.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K202847 (Brainnow Medical Technology Limited, 2021) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K061855.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

The NeuroReader Medical Image Processing Software is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR images.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K140828: Neuroreader Medical Image Processing Software.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K140828

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026